-
Using blood pressure, BUN, serum sodium, and presence of peripheral arterial disease as predictors of mortality in heart failure patients, 67% who had 3 or more factors died within 6 months and would qualify for the Medicare hospice benefit.
-
There are no disease-modifying pharmacotherapies for COPD. That is, although bronchodilators, anticholinergic agents, and inhaled corticosteroids improve FEV1 and reduce symptoms, decline in pulmonary function continues unabated and lung function returns promptly to pretreatment status once medication is stopped.
-
Between March, 2005 and June 2007, 1622 consecutive patient charts at Temple University Hospital were reviewed to determine whether prophylactic antibiotics were used appropriately with regard to antibiotic choice, timing of administration, and postoperative cessation of antibiotics.
-
The current classification for endometrial cancer incorporates the histological assessment of the regional lymph node to assign stage.
-
Two clinical trials compared rivaroxaban vs enoxaparin prophylactic treatment to prevent venous thromboembolism (VTE) after total hip or knee arthroplasty.
-
-
-
These Israeli researchers assigned 44 women with overactive bladder alternately into 2 groups: one group receiving 3 months of pelvic floor rehabilitation, and the other receiving oxybutynin.
-
Cho and colleagues studied 47 women with ultrasound-proven adenomyosis over a 3-year time period.
-
Often there are articles in the ultrasound literature that have diagnostic implications extending far past the ultrasound findings that were the centerpieces of these papers.